Achilles Therapeutics plc Quarterly Accrued Liabilities, Current in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Achilles Therapeutics plc quarterly Accrued Liabilities, Current history and growth rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Accrued Liabilities, Current for the quarter ending June 30, 2024 was $7.23M, a 4.55% decline year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.23M -$344K -4.55% Jun 30, 2024 6-K 2024-08-14
Q4 2023 $7.83M -$464K -5.6% Dec 31, 2023 6-K 2024-08-14
Q2 2023 $7.57M Jun 30, 2023 6-K 2023-08-04
Q4 2022 $8.29M -$2.61M -24% Dec 31, 2022 20-F 2024-04-04
Q4 2021 $10.9M +$4.32M +65.5% Dec 31, 2021 20-F 2023-03-07
Q4 2020 $6.59M Dec 31, 2020 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.